Company intelligence / Profile preview
Nanchang Hongyi Pharmaceutical
Nanchang, Jiangxi, Chinaappsruntheworld.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Nanchang Hongyi Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and manufacturing of small molecule drugs. Its lead clinical programs are in Phase 1 trials targeting oncology and autoimmune diseases, including advanced solid tumors, systemic lupus erythematosus, and leukemias. The company has received GMP certification for its manufacturing facilities.
- Therapeutic areas
- ImmunologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Nanchang Hongyi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanchang Hongyi Pharmaceutical.